Načítá se...
Immunotherapy in metastatic prostate cancer
INTRODUCTION: Prostate cancer remains a challenge as a target for immunological approaches. The approval of the first cell-based immune therapy, Sipuleucel-T for prostate cancer introduced prostate cancer as a solid tumor with the potential to be influenced by the immune system. METHODS: We reviewed...
Uloženo v:
| Vydáno v: | Indian J Urol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5054656/ https://ncbi.nlm.nih.gov/pubmed/27843208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.191240 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|